News Reports

CCTV-NEWS | GV-971, a novel AD drug treatment developed by Chinese research team, grabs much of attention at CTAD
Date:2018-10-30

1540877333503831.jpg



ShareTo:
Previous Page:
Fits and Starts: Trial Results from the CTAD Conference
Next Page:
YAHOO! | Innovative Alzheimer's Treatment from China Concludes Phase 3 Clinical Trials